The Latest Breaking News on Pharma

Pfizer (PFE) played a pivotal role in developing vaccines and pills that helped the world return to normal from the COVID-19 pandemic. The company reported record revenue and earnings in fiscal 2022. Given the company’s solid growth prospects, it could be wise to invest in the stock right now. Keep…

163% more women would lose access to abortion care if the FDA's approval of mifepristone is revoked.

Oak Street Health runs primary care centers mostly for lower-to-middle income people with Medicare Advantage plans.

University spin-out takes on new leadership as it looks towards international growth

Medical stock Zoetis (ZTS) has witnessed steady growth despite the market turbulence in the past few months. Moreover, Wall Street analysts expect the stock to soar further. So, considering its robust fundamentals, ZTS might be worth buying now. Keep reading.

The pharma giant’s UK chief is adding the company’s voice to scientists’ warnings of the dangers of antibacterial resistance

Edinburgh-based start-up will now be able to accelerate development of its life sciences technology

Unite chiefs say their members are determined to get 'what they are owed' in bonus payments row.

Mckesson Corporation (MCK) delivered better-than-expected earnings for the last quarter and updated its outlook for fiscal 2023. Wall Street analysts expect the stock to rise more than 18% in the near term. Therefore, it could be wise to buy this medical stock now. Read more….